missing translation for 'onlineSavingsMsg'
Learn More

CD19 Mouse anti-Human, Brilliant Violet 711, Clone: SJ25C1, BD

Mouse Monoclonal Antibody

203.00 EUR - 436.66 EUR

Specifications

Antigen CD19
Clone SJ25C1
Applications Flow Cytometry
Classification Monoclonal
Conjugate Brilliant Violet 711
View More Specs

Products 2
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
15852459
View Documents
BD Biosciences
563038
25 Tests
ONLINE EXCLUSIVE PRICE
204.00 EUR
203.00 EUR / Each
Save 1.00 EUR
0.49% Off
View alternative products
Save Up to 
»
Please to purchase this item. Need a web account? Register with us today!
15832459
View Documents
BD Biosciences
563036
100 Tests
ONLINE EXCLUSIVE PRICE
440.00 EUR
436.66 EUR / Each
Save 3.34 EUR
0.76% Off
View alternative products
Save Up to 
»
Please to purchase this item. Need a web account? Register with us today!
Description

Description

The SJ25C1 monoclonal antibody specifically binds to CD19, a B lymphocyte-lineage differentiation antigen. CD19, a 90-kDa transmembrance glycoprotein, is a member of the immunoglobulin superfamily and is expressed throughout B-lymphocyte development from the pro-B cell through the mature B-cell stages. Terminally differentiated plasma cells do not express CD19. On the surface of mature B cells, the CD19 molecule associates with CD21 (CR-2) and CD81 (TAPA-1), and this multimolecular complex synergizes with surface immunoglobulin to promote cellular activation. Studies with CD19-deficient mice have suggested that the level of CD19 expression affects the generation and maturation of B cells in the bone marrow and periphery. B-1 lineage B cells, also known as CD5+ B cells, are drastically reduced or absent in CD19-deficient mice. Increased levels of CD19 expression correlate with increased frequencies of peritonal and splenic B-1 cells and reduced numbers of conventional B lymphocytes in the periphery. CD19 participates in B-lymphocyte development, B-cell activation, maturation of memory B cells and regulation of tolerance. CD19 has also been detected on peritoneal mast cells, co-localized with CD21/CD35, and it is proposed to play a role in complement-mediated mast-cell activation.

The antibody was conjugated to BD Horizon™ BV711 which is part of the BD Horizon™ Brilliant Violet™ family of dyes. This dye is a tandem fluorochrome of BD Horizon™ BV421 with an Ex Max of 405-nm and an acceptor dye with an Em Max at 711-nm. BD Horizon™ BV711 can be excited by the violet laser and detected in a filter used to detect Cy™5.5 / Alexa Fluor™ 700-like dyes (eg, 712/20-nm filter). Due to the excitation and emission characteristics of the acceptor dye, there may be moderate spillover into the Alexa Fluor™ 700 and PerCP-Cy™5.5 detectors. However, the spillover can be corrected through compensation as with any other dye combination.

Specifications

Specifications

CD19
Flow Cytometry
Brilliant Violet 711
RUO
Aqueous buffered solution containing BSA and ≤0.09% sodium azide.
IgG1 κ
Affinity Purified
B4; B-lymphocyte antigen CD19; Leu-12
SJ25C1
Monoclonal
Mouse
Human
Human NALM1 + NALM16 cells
Primary
Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze.
Videos
SDS
Documents

Documents

Product Certifications

For Research Use Only.

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.